Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Months After COVID-19 Infection, Rheumatic-Like Symptoms Persist

Mary Beth Nierengarten  |  Issue: April 2021  |  April 16, 2021

The Needs of Long-Haulers

Post-COVID Care Centers are one way the healthcare system is addressing this new patient population. According to an NBC News report, more than 80 of these centers exist nationwide and at least 10,000 people have been seen in 64 of the centers surveyed.8 (View an interactive map with a list of these centers by state on Survivors Corps, a patient website.) These centers provide a multi­disciplinary team approach to the evaluation and management of post-COVID patients with persistent symptoms.

Joan Bosco, MD, assistant professor, Department of Internal Medicine, Mount Sinai, N.Y., works in the Mount Sinai Center for Post-COVID Care, one of the first of these centers to open, in May 2020. She emphasizes how significant and scary these persistent symptoms can seem, particularly when they present in previously healthy young people.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“The most dramatic post-COVID presentation we are seeing is COVID fatigue, with symptoms indicative of a dysregulation of the autonomic nervous system that result in elevated heart rates and drops in blood pressure,” she says, adding the most severely affected patients have a hard time getting out of bed on some days.

Dr. Bosco

Dr. Bosco

In the sample of 47 new patients she and her team saw in June/July 2020, Dr. Bosco says 24 had fatigue, 21 were short of breath, 17 had memory issues or cognitive impairment, 16 had neuropathy, 15 had anxiety or nightmares, and 11 had loss of smell or distorted taste. Although assessment of these patients initially included imaging studies and other laboratory tests, Dr. Bosco notes the center no longer routinely uses these tests because, for the most part, the tests came back normal.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“The center is still ordering extensive lab tests and imaging, but doctors are more discerning in what studies they order [because] many routine studies will be normal in a good percentage of these patients,” she says.

As of January 2021, Dr. Bosco says the center was seeing about 170 new patients per month. Each patient undergoes an initial evaluation and is then referred to whatever specialist within their network—or in the patient’s network, if different—that the symptoms warrant. Patients are asked to return at six months for a follow-up evaluation.

“The one thing that seems to be helping is physical therapy, but it’s a gradual process,” she says. “We have a post-rehab program with a special protocol for post-COVID-19 patients.”

Further information on clinical experience in providing post-acute COVID-19 care to patients with persistent symptoms can be found online in a January 2021 webinar sponsored by the Centers for Disease Control & Prevention.

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:Conditions Tagged with:coughCOVID-19dyspneafatigueneuropsychiatric

Related Articles

    The Many Facets of COVID-19: Experts Address Basic & Clinical Research Concepts in the COVID-19 Era

    November 23, 2021

    New concepts in autoimmunity & immunology are being discovered daily in research being conducted to understand the SARS-CoV-2 virus and its implications for rheumatology & all fields of medicine. Here are some insights shared by experts during day 1 of the Basic and Clinical Research Conference.

    Research Helps Explain Idiosyncrasies of COVID-19

    November 23, 2021

    The Basic and Clinical Research Conference session on Rheumatology Complications of Emerging Viral Infections/SARS-CoV-2 presented findings from numerous studies that help explain some of the idiosyncrasies of COVID-19.

    Bernard Chantal / shutterstock.com

    Diagnostic Challenges of MIS-C

    May 12, 2022

    During the peak of the coronavirus pandemic in Washington, D.C., we were asked to evaluate a 14-year-old boy admitted to the pediatric hospitalist service. He had been healthy until two weeks before, when he noted a sore throat, and soon after he developed fevers and rashes without congestion, shortness of breath, conjunctivitis or swollen lymph…

    Serological Antibody Tests in COVID-19: Test Reliability and Utility

    June 10, 2020

    Serological testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies may play a critical role in the management of the worldwide health crisis. Such testing may reveal key information for epidemiology, convalescent plasma therapies and vaccine development. However, the situation is complex, and much is unknown. Although such testing may ultimately be used to…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences